LAS VEGAS, Nev.--(BUSINESS WIRE)--Jaswinder Grover, MD, Board-certified orthopedic and spine surgeon with much than 25 years of acquisition successful the aesculapian field, has been appointed to the Medical Advisory Board of Harvard MedTech.
“Dr. Grover’s breadth of acquisition successful orthopedics, spine country and aesculapian technology/devices volition supply an important position successful however workers are treated and retrieve from workplace injuries,” noted Gerry Stanley, M.D., Chief Medical Officer, Harvard MedTech. “Our Medical Advisory Board volition payment greatly from his years of managing the attraction of employees who person suffered workplace trauma arsenic good arsenic his years of penetration successful aesculapian instrumentality and aesculapian exertion development.”
Harvard MedTech is an innovative integer wellness institution that is tapping the caller subject of however the encephalon works to alleviate the effects of trauma, including pain, PTSD, anxiety, slump and slumber disorders. The company’s Vx® Therapy level integrates specially designed virtual world experiences, psychosocial support, integer engagement, and proprietary AI algorithms to retrain neural pathways successful the brain. The therapy has been proven to amended attraction outcomes successful worker’s compensation patients and others suffering from symptom and trauma.
Dr. Grover is Founder and proprietor of the Allegiant Institute and Smoke Ranch Surgery Center. He is simply a subordinate of the American Medical Association, UCLA Aesculapian Society, Nevada Orthopedic Association, and Clark County Medical Society.
The intent of the Harvard MedTech Medical Advisory Board is to foster industry-wide innovation astir Vx® Therapy successful the attraction of workplace trauma. Vx® Therapy is simply a disruptive attack that uses virtual reality, behavioral coaching and artificial quality to change the brain’s acquisition of pain, without drugs oregon unnecessary surgery. Each member’s circumstantial expertise lends a peculiar lens connected symptom absorption which has been determined to person important strategical importance, arsenic Harvard MedTech works to marque the satellite a amended spot by alleviating quality suffering.
"I volition beryllium astir funny successful focusing connected however Harvard MedTech’s Vx® Therapy tin supply an alternate solution to pharmacologic approaches to the pain, slump and anxiousness associated with workplace injuries, and successful patients successful general,” Dr. Grover stated. “This is simply a therapy that tin supply a cost-efficient alternate with semipermanent benefits for workers.”
“We are excited to person Dr. Grover articulation our Medical Advisory Board, some for his outstanding objective expertise and acquisition and for his insights arsenic an highly palmy doc entrepreneur,” said Shan Padda, Chief Executive Officer and laminitis of Harvard MedTech. “His signifier is 1 of the champion tally practices, operationally and administratively, that I person seen successful the market. Physicians are important partners for america arsenic we accelerate the rollout of our solution, and Advisory Board members similar Dr. Grover volition assistance america guarantee that our programme plan is optimized for doc engagement and oversight.”
About Harvard MedTech
Harvard MedTech’s Vx® Therapy exemplary is unsocial successful that it is the archetypal to afloat integrate integer technologies with behavioral wellness interventions successful a virtual exertion that tin beryllium managed successful the patient’s home. This virtual engagement drives higher compliance, amended diligent restitution and maximal outcomes. It besides allows the solution to beryllium affordable and scalable astatine a colonisation wellness level. This non-invasive and non-pharmacological attack besides provides information that is trackable for a wide appraisal of its worth to patients and wellness attraction providers. Visit www.harvardmedtech.com for much information.